Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Sep;55(9):616–621. doi: 10.1136/ard.55.9.616

Antibody deficiency associated with gold treatment: natural history and management in 22 patients.

N Snowden 1, D M Dietch 1, L S Teh 1, R C Hilton 1, M R Haeney 1
PMCID: PMC1010257  PMID: 8882131

Abstract

OBJECTIVE: To perform a clinical and immunological study of patients with rheumatoid arthritis who develop subnormal serum immunoglobulins on gold treatment; to clarify the nature of the defect in antibody production and determine the natural history of this adverse reaction; to use this information to suggest guidelines for the detection, investigation, and management of this complication. METHODS: 22 patients who developed subnormal levels of one or more immunoglobulin isotypes while receiving gold treatment were recruited over a 10 year period from the practice of a single rheumatologist. Antibody production was assessed by measurement of total immunoglobulins and of specific antibody production against polysaccharide and protein antigens, with test immunisation if necessary. RESULTS: Two broad patterns of antibody deficiency were identified: (1) (n = 11) mild, affecting only one immunoglobulin isotype and with normal specific antibody production. These patients were in general able to continue gold without further deterioration in antibody production. (2) (n = 11) severe, affecting two or three immunoglobulin isotypes, with defective specific antibody production. Six patients developed significant infections and were treated with immunoglobulin. Gold was discontinued in all. Normal antibody production recovered in nine patients, and in all but one followed for more than one year. No relation was seen between duration/dose of gold and antibody deficiency. CONCLUSIONS: Gold-induced antibody deficiency may be more common than usually recognised. A spectrum of deficiency exists, with some patients developing infective complications. Antibody production should be monitored in patients on gold treatment.

Full text

PDF
616

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bansal A. S., Moran A., Potter M., Taylor R., Haeney M. R., Mandal B. K. Lymphocyte transformation responses to phytohaemagglutinin and pokeweed mitogen in patients at differing stages of HIV infection: are they worth measuring? J Clin Pathol. 1993 Sep;46(9):846–848. doi: 10.1136/jcp.46.9.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burns H. J., Klimiuk P. S., Hilton R. C., Haeney M. Gold-induced hypogammaglobulinaemia. Br J Rheumatol. 1987 Feb;26(1):53–55. doi: 10.1093/rheumatology/26.1.53. [DOI] [PubMed] [Google Scholar]
  3. Chapel H. M. Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. BMJ. 1994 Feb 26;308(6928):581–585. doi: 10.1136/bmj.308.6928.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farr M., Kitas G. D., Tunn E. J., Bacon P. A. Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis. Br J Rheumatol. 1991 Dec;30(6):413–417. doi: 10.1093/rheumatology/30.6.413. [DOI] [PubMed] [Google Scholar]
  5. Guillemin F., Bene M. C., Aussedat R., Bannwarth B., Pourel J. Hypogammaglobulinemia associated with gold therapy: evidence for a partial maturation blockade of B cells. J Rheumatol. 1987 Oct;14(5):1034–1035. [PubMed] [Google Scholar]
  6. Hazlewood M., Nusrat R., Kumararatne D. S., Goodall M., Raykundalia C., Wang D. G., Joyce H. J., Milford-Ward A., Forte M., Pahor A. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol. 1993 Aug;93(2):157–164. doi: 10.1111/j.1365-2249.1993.tb07959.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hunter T. Hypogammaglobulinaemia associated with gold therapy. Ann Rheum Dis. 1985 Mar;44(3):212–212. doi: 10.1136/ard.44.3.212-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jefferis R., Kumararatne D. S. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990 Sep;81(3):357–367. doi: 10.1111/j.1365-2249.1990.tb05339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lee A. H., Levinson A. I., Schumacher H. R., Jr Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum. 1993 Feb;22(4):252–264. doi: 10.1016/0049-0172(93)80073-o. [DOI] [PubMed] [Google Scholar]
  10. Lorber A., Simon T., Leeb J., Peter A., Wilcox S. Chrysotherapy. Suppression of immunoglobulin synthesis. Arthritis Rheum. 1978 Sep-Oct;21(7):785–791. doi: 10.1002/art.1780210708. [DOI] [PubMed] [Google Scholar]
  11. Mitchell D. M., Spitz P. W., Young D. Y., Bloch D. A., McShane D. J., Fries J. F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986 Jun;29(6):706–714. doi: 10.1002/art.1780290602. [DOI] [PubMed] [Google Scholar]
  12. Olson J. C., Lovell D. J., Levinson J. E. Hypogammaglobulinemia associated with gold therapy in a patient with juvenile rheumatoid arthritis. J Rheumatol. 1986 Feb;13(1):224–225. [PubMed] [Google Scholar]
  13. Pincus T., Callahan L. F. Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. J Rheumatol. 1986 Oct;13(5):841–845. [PubMed] [Google Scholar]
  14. Shadick N. A., Fanta C. H., Weinblatt M. E., O'Donnell W., Coblyn J. S. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994 May;73(3):161–170. [PubMed] [Google Scholar]
  15. So A. K., Peskett S. A., Webster A. D. Hypogammaglobulinaemia associated with gold therapy. Ann Rheum Dis. 1984 Aug;43(4):581–582. doi: 10.1136/ard.43.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stanworth D. R., Williamson J. P., Shadforth M., Felix-Davies D., Thompson R. Drug-induced IgA deficiency in rheumatoid arthritis. Lancet. 1977 May 7;1(8019):1001–1002. doi: 10.1016/s0140-6736(77)92297-8. [DOI] [PubMed] [Google Scholar]
  17. Wheeler J. G., Steiner D. Evaluation of humoral responsiveness in children. Pediatr Infect Dis J. 1992 Apr;11(4):304–310. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES